drugset / Trial / NCT00181922

Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder

NCT00181922

Phase 4 Completed 20 enrolled Massachusetts General Hospital Pfizer · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The objective of this study is to compare the safety and effectiveness of Ziprasidone in the treatment of mania in children and adolescents with Bipolar disorder over 8 weeks. This is an exploratory, open-label study, which seeks to determine if there is evidence for efficacy. The results of this study will be used to generate hypotheses for a larger study.

Timeline

Start
2002-03
Primary completion
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ziprasidone Small molecule